Phase 3 Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to give your consent to take part in the study.
- You are between 60 and 90 years old (any gender).
- You have been diagnosed with mild to moderate Alzheimer's disease, AND either: you have been taking memantine (20 mg daily) for at least 2 months (Groups 1 & 2), OR you have not been taking any Alzheimer's medications for the past 2 or more months (Group 3).
- Your score on a standard memory and thinking test called the MMSE falls between 10 and 23.
- Your score on another cognitive assessment called the ADAS-Cog falls between 20 and 54.
- A brain scan (CT or MRI) shows no signs that your dementia is caused by problems with blood flow to the brain.
- A test called the Modified Hachinski Ischemic Scale shows a score below 7, suggesting your dementia is not related to blood vessel problems.
- You have a caregiver who spends a significant amount of time with you, is willing to come to all study visits with you, help you take the study medication, and fill out a diary about your health.
- You are able to follow all the requirements of the study.
Who may not be able to join:
- You have another illness that is known to cause dementia (such as severe thyroid problems, severe anemia, a brain tumour, or a brain infection).
- You have a history of other brain or nervous system conditions, such as Parkinson's disease, multiple sclerosis, uncontrolled epilepsy, hallucinations, or other conditions that seriously affect your movement or thinking.
- You have had an allergic or bad reaction to any ingredient in the study drug in the past.
- You have a history of stroke.
- You currently have an active cancer.
- You are expected to need surgery on the blood vessels in your neck or brain during the study period.
- You have a significant uncontrolled health condition that the study doctor believes would prevent your safe participation, including serious problems with your lungs, heart, kidneys, liver, hormonal system, or digestive system.
- You have a systemic autoimmune disease (such as lupus) that requires or has required treatment with systemic medications.
- You had a heart attack within the 12 months before joining the study.
- You have a known ongoing infection such as hepatitis, HIV, tuberculosis, or syphilis.
- Your doctors expect you to live less than one year.
- You have taken certain medications that can affect memory or thinking (such as some antidepressants, sleeping pills, or antipsychotics), or certain other prohibited medications, within 1 month before the study start.
- You have moderate to severe depression, as measured by a score of 18 or more on the Hamilton Depression Scale.
- You are a smoker.
- You have had issues with alcohol or drug misuse in the past 6 months.
- The study doctor believes you would not be able to follow the study procedures, even with help.
- You have taken part in another clinical trial within the past 6 months.
- You have another serious or unstable mental health condition that could affect your ability to safely take part or to give informed consent.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assessment of the change in ADAS-Cog Scale overall score at Week 26 compared to baseline (Week 0) in patients receiving DMB-I (Group 1) Vs. patients receiving placebo (Group 2)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.